A clinical-stage biotech company developing proprietary oncolytic peptides as a novel immune therapy to fight cancer.
View all
Flow Robotics
Copenhagen, Denmark
Ultimovacs
Post IPO Equity • Oslo, Norway
BioMarin Pharmaceutical
Post IPO Debt • San Rafael, United States
Verve Therapeutics
Series B • Cambridge, United States
BenevolentAI
Private Equity • England, United Kingdom
Biogen
Cambridge, United States
Imvax
Series C • Philadelphia, United States
Guardant Health
Venture • Redwood City, United States
Genentech
Venture • South San Francisco, United States
EXACT Therapeutics
Oslo, Norway
Celsius Therapeutics
Series B • Cambridge, United States
ARCA biopharma
Westminster, United States